Icon
+91 94997 68112
Login Register

RECARBRIO - (500MG;500MG;250MG)

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM None
500MG;500MG;250MG
Less Than $1000 mn
None None
None None
None None
RECARBRIO is a combination of imipenem, a penem antibacterial, cilastatin, a renal dehydropeptidase inhibitor, and relebactam, a betalactamase inhibitor, indicated in patients 18 years of age and older for the treatment of the following infections caused by susceptible gram-negative microorganisms:  Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP)  Complicated urinary tract infections, including pyelonephritis (cUTI) in patients who have limited or no alternative treatment options.  Complicated intra-abdominal infections (cIAI) in patients who have limited or no alternative treatment options
Yes
RECARBRIO Patent 1
*** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.